Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $13.08 Analyst target: $20.59 Upside: 57.42%
HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central, Hong Kong.
See the full interactive analysis & chart →Informational only — not investment advice.